Intelligence · Clinical Pipeline
Autoimmune & immunology · Phase I
Autoimmune & immunology programs at Phase I — ClinicalTrials.gov pipeline intelligence.
- Programs
- 167
Quick answer
Autoimmune & immunology Phase I programs: NovaPharmaNews indexes 167 matching clinical development programs from ClinicalTrials.gov with sponsor, modality, and NCT cross-links.
Top sponsors
- Anaxis Pharma 19 programs
- Chinese Academy of 15 programs
- Takeda 8 programs
- Chongqing Precision Biotech 6 programs
- Nanjing Legend Biotech 6 programs
- Lakefront Biotherapeutics NV 5 programs
- MSD Merck Sharp 5 programs
- Regeneron UK 5 programs
- AstraZeneca 4 programs
- First People's Hospital 4 programs
- Sunshine Guojian Pharmaceutical 4 programs
- Century Therapeutics 3 programs
-
TD-1473
Theravance Biopharma Ireland Umited
Ulcerative Colitis, Active Moderate
1 trial -
TD-3504
Theravance Biopharma Ireland Umited
Active Mild Ulcerative Colitis, Active Moderate Ulcerative Colitis, Healthy Subjects
1 trial -
TL011, anti CD20, for the treatment of rheumatoid arthritis
Teva Pharma GmbH
Rheumatoid Arthritis
1 trial -
The CALiPSO-1 Study: A Study of CNTY-101, a CD19-targeted CAR iNK Cell Product, in Participants with Refractory B cell-mediated Autoimmune Diseases
Century Therapeutics
systemic lupus erythematosus [SLE]/lupus nephritis [LN], idiopathic inflammatory myopathy [IIM], and diffuse cutaneous systemic sclerosis [DcSSc]
1 trial -
ThisCART19A
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Autoimmune Hemolytic Anemia
1 trial -
Triamcinolone Acetonide Extended-Release Injectable Suspension
Pacira Ireland Limited
Osteoarthritis, Knee
1 trial -
UB-VV410
The First People's Hospital of Lianyungang
Systemic Lupus Erythematosus
1 trial -
UTAA91 injection
Hospital Authority, Hong Kong
Rheumatoid Arthritis (RA)
1 trial -
UTAA91 injection
Suzhou Ribo Life Science Co.
Rheumatoid Arthritis (RA)
1 trial -
Vonsetamig
Regeneron UK Limited
Lupus Nephritis (LN)
1 trial -
Western medicine
Universal Integrated
Psoriasis
1 trial -
YTS109 cell
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Autoimmune Hemolytic Anemia
1 trial -
YTS109 cell
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Systemic Lupus Erythematosus
1 trial -
YTS109 cell
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Systemic Lupus Erythematosus (SLE)
4 trials -
YTS109 cell injection
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Lupus Nephritis (LN)
1 trial -
anti-CD19-CAR-T cells
Chongqing Precision Biotech Co., Ltd
Systemic Lupus Erythematosus
1 trial -
anti-thymocyte globulin
Ultragenyx UK Limited
Systemic Lupus Erythematosus
1 trial -
lumbar puncture
Takeda
Crohn's Disease
1 trial -
milatuzumab
United Therapeutics Europe Ltd
Lupus Erythematosus, Cutaneous
1 trial -
namilumab (MT203)
Takeda
Rheumatoid Arthritis
1 trial -
riliprubart
Vera Therapeutics
Autoimmune haemolytic anaemia
1 trial -
rilonacept (IL-1 Trap)
Regeneron UK Limited
Systemic Juvenile Idiopathic Arthritis
1 trial -
sarilumab SAR153191 (REGN88)
Sanofi Pasteur
Rheumatoid Arthritis
1 trial
Frequently asked questions
How many autoimmune & immunology Phase I programs exist?
167 programs match both the therapeutic area and stage filters in our published index.
Data attribution: Data sources · All pipeline programs